![Chris Nave](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Nave
Direttore/Membro del Consiglio presso
EBR SYSTEMS, INC.
Patrimonio netto: - $ in data 30/06/2026
Profilo
Dr. Chris Nave is a Chairman at PolyActiva Pty Ltd., a Founding Partner & Managing Director at Brandon Capital Partners Pty Ltd., a Chairman at OccuRx Pty Ltd, a Chief Executive Officer at Medical Research Commercialisation Fund Trust, a Director & Member at Australian Investment Council Ltd., a Member at AusBiotech Ltd. and a Member at BioMelbourne Network.
He is on the Board of Directors at EBR Systems, Inc., Osprey Medical, Inc., Azura Ophthalmics Ltd., BACE Therapeutics Pty Ltd., Cardiora Pty Ltd., Certa Therapeutics Pty Ltd., Global Kinetics Pty Ltd., Pathios Therapeutics Ltd., QUE Oncology, Inc. and Australian Investment Council Ltd.
Dr. Nave was previously employed as a Director-Commercialization by Alfred Health, a Commercialization Director by Baker Heart & Diabetes Institute, a Manager by Melbourne Ventures Pty Ltd., and a Non-Executive Director by Otifex Therapeutics Pty Ltd. He also served on the board at Athena Medicines Pty Ltd., Fibrotech Therapeutics Pty Ltd., Hatchtech Pty Ltd. and Spinifex Pharmaceuticals Pty Ltd.
He received his undergraduate degree from the University of Melbourne and a doctorate degree from the University of Melbourne.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EBR SYSTEMS, INC. -.--% | 29/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Chris Nave
| Società | Posizione | Inizio |
|---|---|---|
| OSPY MEDI CDI | Direttore/Membro del Consiglio | 24/10/2005 |
| EBR SYSTEMS, INC. | Direttore/Membro del Consiglio | 01/10/2017 |
OccuRx Pty Ltd
 OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Presidente | - |
Certa Therapeutics Pty Ltd.
 Certa Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company, which develops drugs for treatment for fibrotic diseases | Direttore/Membro del Consiglio | - |
Australian Investment Council Ltd.
 Australian Investment Council Ltd. Miscellaneous Commercial ServicesCommercial Services Represents the private equity and venture capital industry | Direttore/Membro del Consiglio | - |
Medical Research Commercialisation Fund Trust
 Medical Research Commercialisation Fund Trust Investment ManagersFinance Acts as Venture Capital Fund | Amministratore Delegato | - |
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Direttore/Membro del Consiglio | - |
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in focused on preventing and treating life-threatening cancers and related conditions | Direttore/Membro del Consiglio | - |
Cardiora Pty Ltd.
 Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund | Direttore/Membro del Consiglio | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Precedenti posizioni note di Chris Nave
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Chris Nave
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
99
Relazioni di 1° grado
25
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 25 |
|---|---|
EBR Systems, Inc.
 EBR Systems, Inc. Medical SpecialtiesHealth Technology Develops implantable systems for wireless tissue stimulation | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Investment Council Ltd.
Australian Investment Council Ltd. Miscellaneous Commercial ServicesCommercial Services Represents the private equity and venture capital industry | Commercial Services |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Osprey Medical, Inc.
 Osprey Medical, Inc. Medical SpecialtiesHealth Technology Develops medicine for cardiovascular diseases | Health Technology |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical product company | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Melbourne Ventures Pty Ltd.
 Melbourne Ventures Pty Ltd. Investment ManagersFinance Offers commercial advisory and technology commercialization services | Finance |
Medical Research Commercialisation Fund Trust
Medical Research Commercialisation Fund Trust Investment ManagersFinance Acts as Venture Capital Fund | Finance |
BioMelbourne Network | |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Alfred Health
 Alfred Health Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
Fibrotech Therapeutics Pty Ltd.
 Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops novel drugs candidates for the treatment of the fibrosis prevalent | Health Technology |
Otifex Therapeutics Pty Ltd.
 Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Develops treatment for ear diseases | Health Technology |
PolyActiva Pty Ltd.
 PolyActiva Pty Ltd. BiotechnologyHealth Technology Operates as a clinical-stage ophthalmology company that develops drug-polymer conjugate technology | Health Technology |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices for neurology and provides related services | Health Technology |
BACE Therapeutics Pty Ltd. | |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in focused on preventing and treating life-threatening cancers and related conditions | Health Technology |
OccuRx Pty Ltd
OccuRx Pty Ltd Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Azura Ophthalmics Pty Ltd.
 Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Designs ophthalmic keratolytics | Health Technology |
Cardiora Pty Ltd.
Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund | Miscellaneous |
Baker Heart & Diabetes Institute
 Baker Heart & Diabetes Institute Miscellaneous Commercial ServicesCommercial Services Owns and operates medical research institutes | Commercial Services |
Athena Medicines Pty Ltd. | |
Certa Therapeutics Pty Ltd.
Certa Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company, which develops drugs for treatment for fibrotic diseases | Health Technology |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
